BlackRock Amends Quest Diagnostics Stake as of Dec 31, 2023

TL;DR

**BlackRock updated its Quest Diagnostics stake, signaling its latest institutional position.**

AI Summary

BlackRock Inc. has updated its ownership stake in Quest Diagnostics Inc. (NYSE: DGX) as of December 31, 2023, filing an Amendment No. 15 to its Schedule 13G. This filing indicates BlackRock's current holdings, which is important for investors as large institutional ownership can signal confidence in a company's long-term prospects and influence stock stability. Investors should note that BlackRock is a significant institutional holder, and changes in its position can sometimes precede broader market sentiment shifts for Quest Diagnostics.

Why It Matters

This filing shows BlackRock's updated position in Quest Diagnostics, providing transparency on a major institutional investor's confidence in the company. Significant institutional ownership can influence stock liquidity and investor perception.

Risk Assessment

Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate or significant risk to the company or its shareholders.

Analyst Insight

Investors should monitor future 13G/A filings from BlackRock for Quest Diagnostics to track any significant changes in their ownership, as large institutional movements can sometimes influence market perception and stock performance.

Key Players & Entities

• BlackRock Inc. (company) — filing party, institutional investor
• Quest Diagnostics Inc. (company) — subject company, issuer of securities
• December 31, 2023 (date) — date of event requiring the filing
• Amendment No. 15 (dollar_amount) — number of amendments to the Schedule 13G filing

Forward-Looking Statements

• BlackRock will continue to be a significant institutional holder of Quest Diagnostics stock. (BlackRock Inc.) — high confidence, target: 2024-12-31

FAQ

From the Filing

0001086364-24-002677.txt : 20240124 0001086364-24-002677.hdr.sgml : 20240124 20240124172352 ACCESSION NUMBER: 0001086364-24-002677 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-50905 FILM NUMBER: 24557756 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us74834l1008_012424.txt us74834l1008_012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 15) QUEST DIAGNOSTICS INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 74834L100 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 74834L100 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 9735324 (6) Shared voting power 0 (7) Sole dispositive power 10578025 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 10578025 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 9.4% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- QUEST DIAGNOSTICS INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 500 PLAZA DRIVE SECAUCUS NJ 07094 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- Blac